Industry news

Popular Tags

industry life COVID-19 FDA science research Hi-Tech medical technology medindustriya business WHO Trump cancer law Alzheimer's disease Industry homeopathy Alzheimer medical brain medicine investment hepatitis c medical and health genome Alzheimer's multiple sclerosis human brain DNA digital biomarkers Nobel Prize medicine and health Parkinson’s disease diabetes hacker attack Amazon startup biology 3D printing biotechnology charity tecnolgy coronavirus cyber-security vaccine health

December 02, 2020, 12:40

GRAIL and UK Government to Make Galleri Multi-Cancer Early Detection Blood Test Available to Patients

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a partnership with the United Kingdom’s (UK) National Health Service (NHS) to help transform cancer outcomes by making GRAIL’s multi-cancer early detection blood test, Galleri™, available to UK patients starting in 2021.

medindustriya

Site Map